Untargeted Lipidomics in Fabry Disease of Urine Samples by Low-Resolution Flow Injection Mass Spectrometry (ESI(±)-LTQ MS)
Open Access
- 27 June 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (26) , 27869-27882
Abstract
Background: Fabry disease (FD) is a lysosomal storage disease caused by genetic mutations related to the coding of the enzyme α-galactosidase A, which is responsible for the metabolism of glycosphingolipids such as globotriaosylceramide and globotriaosylsphingosine. The accumulation of these and other metabolites can occur in various types of cells and impair the functioning of multiple organs and systems, such as the heart, brain, and kidneys. However, with early diagnosis and appropriate therapeutic intervention, the clinical outcome can be significantly improved. This study aimed to analyze the performance of new diagnostic methods for FD using the broad field of lipidomics combined with multivariate analyses, proposing the use of urine as a specimen. Materials and Methods: urine samples were collected from patients with both confirmed (Case) and negative (Control) diagnoses of FD, which were later processed for specific lipid extraction. After extraction, 81 samples (44 cases and 37 controls) were subjected to mass spectrometry analysis, with direct infusion and electrospray ionization in both positive and negative modes (ESI(±)). After spectral acquisition, the data were processed and analyzed using multivariate analysis methods such as Principal Component Analysis (PCA) and Partial Least Squares Discriminant Analysis (PLS-DA). Results: the combination of both ionization modes for PLS-DA was able to differentiate between the Case and Control groups with 92% accuracy. Conclusion: this paper suggests that the proposed method of application of lipidomics combined with multivariate analyses as a tool for early diagnosis of FD is promising, enabling and contributing to the improvement of healthcare for these patients.Keywords
Funding Information
- Fundação de Amparo à Pesquisa e Inovação do Espírito Santo (019/2022, 23/2018, 596/2018, 711/2022, 979/2023)
- ArcelorMittal
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (23/2018, 310057/2020-5, 54/2022, 596/2018, e 422555/2018-5)
This publication has 45 references indexed in Scilit:
- Three-dimensional enhanced lipidomics analysis combining UPLC, differential ion mobility spectrometry, and mass spectrometric separation strategiesJournal of Lipid Research, 2014
- Lipid quantification method using FTIR spectroscopy applied on cancer cell extractsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Structural characterization of neutral glycosphingolipids using high-performance liquid chromatography-electrospray ionization mass spectrometry with a repeated high-speed polarity and MSn switching systemGlycoconjugate Journal, 2013
- Multiplex Analysis of Novel Urinary Lyso-Gb3-Related Biomarkers for Fabry Disease by Tandem Mass SpectrometryAnalytical Chemistry, 2012
- Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment OutcomePLOS ONE, 2012
- Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometryJournal of Chromatography B, 2012
- Determination of globotriaosylceramide in plasma and urine by mass spectrometryClinical Chemistry and Laboratory Medicine (CCLM), 2009
- Metabolomics: Current technologies and future trendsProteomics, 2006
- Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometryBiochemistry, 1988
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959